Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Read more

Leading people in the age of AI

Read more

Patent expiries ahead, is India Pharma Inc ready?

Read more

Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India

Read more

Mumbai Experience Center reflects Agilent’s continued commitment to India 

Read more

Lupin completes acquisition of VISUfarma

Read more

Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US

Read more

Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai

Read more

Midst global headwinds, CDSCO cracks down on GLP-1 gold rush

Read more

Express Pharma April 2026

Read more